BIO's free cash flow for Q3 2025 was $0.53. For the 2025 fiscal year, BIO's free cash flow was decreased by $ and operating cash flow was $-0.64. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	5.44	5.83	5.55	2.92	3.39
Quick Ratio	5.44	4.34	4.29	2.08	2.40
Cash Ratio	0.76	0.77	0.76	0.69	1.05
Solvency Ratio	-0.17	-0.14	-0.89	1.08	1.29
Operating Cash Flow Ratio	0.94	0.72	0.34	0.96	0.91
Short-Term Operating Cash Flow Coverage	12.90	771.49	418.17	1.34K	442.56
Net Current Asset Value	$ -117.60M	$ -509.61M	$ -728.44M	$ -2.12B	$ -952.84M
Leverage Ratios
Debt-to-Assets Ratio	0.14	0.11	0.09	<0.01	<0.01
Debt-to-Equity Ratio	0.21	0.16	0.12	<0.01	<0.01
Debt-to-Capital Ratio	0.17	0.14	0.11	<0.01	<0.01
Long-Term Debt-to-Capital Ratio	0.15	0.12	0.11	<0.01	<0.01
Financial Leverage Ratio	1.44	1.41	1.40	1.30	1.31
Debt Service Coverage Ratio	-7.26	-7.92	-88.45	2.17K	172.85
Interest Coverage Ratio	4.57	6.83	12.66	315.56	18.80
Debt to Market Cap	0.15	0.13	0.10	<0.01	<0.01
Interest Debt Per Share	53.65	49.81	41.51	0.42	1.21
Net Debt to EBITDA	-1.61	-1.65	-0.17	-0.08	-0.13
Profitability Margins
Gross Profit Margin	52.26%	53.42%	55.93%	56.14%	56.48%
EBIT Margin	-31.03%	-29.97%	-166.51%	186.50%	193.65%
EBITDA Margin	-24.29%	-22.77%	-160.19%	192.55%	200.53%
Operating Profit Margin	8.78%	12.65%	17.22%	16.75%	16.14%
Pretax Profit Margin	-32.95%	-31.82%	-167.87%	186.08%	192.79%
Net Profit Margin	-26.43%	-23.86%	-129.45%	145.57%	149.83%
Continuous Operations Profit Margin	-33.40%	-23.86%	-129.45%	145.57%	149.52%
Net Income Per EBT	80.22%	74.97%	77.11%	78.23%	77.72%
EBT Per EBIT	-375.44%	-251.66%	-974.74%	1111.12%	1194.20%
Return on Assets (ROA)	-6.97%	-5.18%	-26.87%	23.93%	29.40%
Return on Equity (ROE)	-9.97%	-7.29%	-37.73%	31.13%	38.61%
Return on Capital Employed (ROCE)	2.45%	2.87%	3.73%	2.86%	3.33%
Return on Invested Capital (ROIC)	2.47%	2.14%	2.87%	2.23%	2.57%
Return on Tangible Assets	-7.74%	-5.51%	-28.42%	24.77%	30.56%
Earnings Yield	-8.17%	-6.76%	-28.96%	18.87%	21.98%
Efficiency Ratios
Receivables Turnover	5.39	5.46	5.67	6.90	6.07
Payables Turnover	9.48	8.60	9.14	9.03	7.94
Inventory Turnover	0.00	1.59	1.72	2.24	1.78
Fixed Asset Turnover	0.00	3.69	4.12	4.20	3.67
Asset Turnover	0.26	0.22	0.21	0.16	0.20
Working Capital Turnover Ratio	1.12	1.04	1.44	2.08	1.83
Cash Conversion Cycle	29.17	253.35	237.12	175.42	219.21
Days of Sales Outstanding	67.68	66.82	64.43	52.90	60.14
Days of Inventory Outstanding	0.00	228.95	212.61	162.94	205.02
Days of Payables Outstanding	38.51	42.42	39.91	40.42	45.95
Operating Cycle	67.68	295.77	277.03	215.83	265.16
Cash Flow Ratios
Operating Cash Flow Per Share	18.25	12.84	6.53	22.01	19.33
Free Cash Flow Per Share	12.51	7.47	2.70	17.96	16.00
CapEx Per Share	5.75	5.36	3.83	4.05	3.32
Free Cash Flow to Operating Cash Flow	0.69	0.58	0.41	0.82	0.83
Dividend Paid and CapEx Coverage Ratio	2.26	2.39	1.70	5.43	5.82
Capital Expenditure Coverage Ratio	3.18	2.39	1.70	5.43	5.82
Operating Cash Flow Coverage Ratio	0.35	0.27	0.16	59.67	40.93
Operating Cash Flow to Sales Ratio	0.19	0.14	0.07	0.22	0.23
Free Cash Flow Yield	4.06%	2.31%	0.64%	2.38%	2.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-12.24	-14.80	-3.45	5.30	4.55
Price-to-Sales (P/S) Ratio	3.24	3.53	4.47	7.71	6.82
Price-to-Book (P/B) Ratio	1.23	1.08	1.30	1.65	1.76
Price-to-Free Cash Flow (P/FCF) Ratio	24.62	43.21	155.99	42.07	36.42
Price-to-Operating Cash Flow Ratio	16.84	25.15	64.41	34.33	30.16
Price-to-Earnings Growth (PEG) Ratio	0.04	0.18	0.02	0.46	0.04
Price-to-Fair Value	1.23	1.08	1.30	1.65	1.76
Enterprise Value Multiple	-14.95	-17.15	-2.96	3.92	3.27
Enterprise Value	9.29B	10.43B	13.29B	22.08B	16.70B
EV to EBITDA	-14.95	-17.15	-2.96	3.92	3.27
EV to Sales	3.63	3.91	4.74	7.55	6.56
EV to Free Cash Flow	27.58	47.80	165.50	41.22	35.06
EV to Operating Cash Flow	18.90	27.83	68.34	33.63	29.04
Tangible Book Value Per Share	214.30	274.13	298.02	438.00	315.39
Shareholders’ Equity Per Share	250.22	299.26	322.82	458.15	331.90
Tax and Other Ratios
Effective Tax Rate	-0.01	0.25	0.23	0.22	0.22
Revenue Per Share	94.99	91.45	94.08	97.97	85.52
Net Income Per Share	-25.10	-21.82	-121.79	142.61	128.13
Tax Burden	0.80	0.75	0.77	0.78	0.78
Interest Burden	1.06	1.06	1.01	1.00	1.00
Research & Development to Revenue	0.11	0.09	0.09	0.09	0.09
SG&A to Revenue	0.00	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	<0.01	0.02	0.02	0.02	0.02
Income Quality	-0.64	-0.59	-0.05	0.15	0.15

Currency in USD

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing